Literature DB >> 20923901

Enhancing adoptive parenting: a randomized controlled trial.

Alan Rushton1, Elizabeth Monck, Morven Leese, Paul McCrone, Jessica Sharac.   

Abstract

The aim was to conduct a pragmatic randomized controlled trial (RCT) to evaluate two parenting programmes designed for adopters of children late placed from care. Adoptive parents, with children between 3 and 8 years who were screened to have serious behavioural problems early in the placement, participated in home-based, manualized, parenting programmes delivered by trained and supervised family social workers. The adopters who agreed to join the study were randomly allocated to one of two parenting interventions or to a "services as usual" group. Baseline, immediate post-intervention and six-month follow-ups were assessed using questionnaires and adopter interviews. No cases were lost to follow-up at any point and satisfaction was high with both parenting interventions. At the six-month follow-up, a significant difference (p < 0.007) was found for "satisfaction with parenting" in favour of the intervention group (Effect Size d = 0.7). Negative parenting approaches were reduced in the intervention group. However, no significant differences in child problems were found between the intervention groups and control group, adjusting for baseline scores. Costs analysis showed that a relatively modest investment in post-adoption support would be well spent in improving adopters' satisfaction with parenting in the intervention group compared to the routine service group.

Entities:  

Mesh:

Year:  2010        PMID: 20923901     DOI: 10.1177/1359104510365041

Source DB:  PubMed          Journal:  Clin Child Psychol Psychiatry        ISSN: 1359-1045            Impact factor:   2.544


  1 in total

1.  The feasibility of a randomised controlled trial of Dyadic Developmental Psychotherapy.

Authors:  Fiona Turner-Halliday; Nicholas Watson; Nicole R S Boyer; Kathleen A Boyd; Helen Minnis
Journal:  BMC Psychiatry       Date:  2014-12-30       Impact factor: 3.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.